Tag Peter W. Hashim MD MHS

Investigational Therapies for Psoriasis

Key points Investigational therapies aim to inhibit the specific immunologic mechanisms behind plaque psoriasis without widely affecting the normal immune system. Pathways targeted by investigational therapies include Janus kinase, tumor necrosis factor-α, interleukin-17, and interleukin-23. Phase II and phase III…